If you are struggling to lose weight with diet and exercise, speak with your medical team about your options including the use of GLP-1 or GIP agonists
Some of the potential medicines coming down the pipeline include: Survodutide , mazdutide , and pemvidutide , weekly injectable drugs that work on both GLP-1 and glucagon receptors to help reduce weight and lower blood sugar Retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon that comes in a once-weekly injection Pramlintide and cagrilintide, injectable drugs that work by acting on receptors for amylin, a hormone produced by the pancreas that plays a role in blood sugar control and satiety (fullness) How long will I take weight loss medications
35050079, 35050061) is recommended
Unlike traditional medications such as disulfiram, naltrexone, and buprenorphine, which primarily target neurotransmitter pathways directly associated with addiction, GLP-1RAs modulate reward mechanisms indirectly through metabolic and neuroendocrine pathways
A peptide is a chain of amino acids held together by peptide bonds, and those bonds are precisely what digestive enzymes (pepsin, trypsin) are built to cut, with the acidic stomach environment finishing the job so an oral peptide is largely destroyed before it can be absorbed, which is why injection is the default